C21 Investments Announces Q4 Earnings Date and Provides Operational Update
Sequential Same Store Sales Growth Across All Dispensaries Continues Strong Outlier Performance
VANCOUVER, BC, May 22, 2025 /CNW/ - C21 Investments Inc. (CSE: CXXI and OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced its expected date for reporting its audited fiscal year end financial results for the period ended March 31, 2025. The Company is also taking the opportunity to provide an operational update for the period. All currency is reported in U.S. dollars. The Company recently changed its fiscal reporting period to a March 31st year-end and will not have traditional year-over-year comparable reporting periods for its fourth quarter.
The Company is pleased to share an update on its existing operations for its fourth quarter, ended March 31, 2025. C21 anticipates releasing audited results by June 24, 2025.
For Q4 (January–March 2025), C21 reported revenue of $8.1 million, a 3% increase from $7.9 million in Q3 (October–December 2024). Compared to the previous Q4 (ended January 31, 2024), revenue grew by 24%. Gross margins for Q4 are projected at approximately 45%. Over the fiscal year (Q4 vs. Q1), C21 achieved a 23% revenue increase (see table below). The company sustained robust retail sales growth, with a 26% increase over the same period.
All Silver State Relief dispensaries recorded sequential same-store sales growth in Q4. Notably, the South Reno store, opened in July 2024, has achieved over 100% same-store sales growth, rising from $273,000 in its first full operational month, July 2024, to $580,780 in March 2025. Customer transactions grew consistently across all dispensaries each quarter, with a 38% increase in retail transactions over the fiscal year (Q4 vs. Q1).
CEO and President, Sonny Newman, stated, "We look forward to sharing our fourth quarter and year-end results in June, which will showcase sequential same store sales growth across each of our Silver State Relief dispensaries despite seasonal and industry challenges. Our performance underscores the strength of our retail brand and the exceptional dedication of our team."
In USD
Preliminary Q4
Q3
Q2
Q1
2-month StubMar 31, 2025
Dec 31, 2024
Sept 30, 2024
June 30, 2024
Mar 31, 2024
Revenue
$ 8,105,512
$ 7,907,812
$ 7,508,547
$ 6,596,009
$ 4,464,950
Gross Margin
45 %
46 %
43 %
31 %
40 %
Income (Loss)from Operations
$ 837,212
$ 978,114
$ 306,586
$ (840,256)
$ 289,906
Adjusted EBITDA[1]
$ 1,692,102
$ 1,567,599
$1,295,317
$ 310,818
$ 632,526
Free Cash Flow1
$ 1,602,912
$ 1,581,843
$ 984,774
$ (91,845)
$ 399,523
Customer Transactions
174,611
168,457
154,911
126,449
80,712
Non-GAAP Measures:
C21 reports its financial results in accordance with GAAP and uses a number of financial measures when assessing its results and measuring overall performance. Some of these financial measures and ratios are not calculated in accordance with GAAP. The Company refers to certain Non-GAAP financial measures such as "Free Cash Flow", "Adjusted EBITDA" and "same store sales". These measures do not have any standardized meanings prescribed by GAAP and may not be comparable to similar measures presented by other issuers. The Company considers these measures to be an important indicator of the financial strength and performance of its business. The Company believes the adjusted results presented provide relevant and useful information for investors because they clarify the Company's actual operating performance, make it easier to compare the Company's results with those of other companies and allow investors to review performance in the same way as the management of the Company. Since these measures are not calculated in accordance with GAAP, they should not be considered in isolation of, or as a substitute for, the Company's reported results as indicators of the Company's performance, and they may not be comparable to similarly named measures from other companies. The tables below provide reconciliations of Non-GAAP financial measures to the most directly comparable GAAP measures.
"Free Cash Flow" is defined as Cash Provided by Operating Activities from Continuing Operations adding back income tax expense and before changes in working capital, minus capital expenditures. Management believes that Free Cash Flow, which measures our ability to generate cash from our continuing business operations, is an important financial measure for use in evaluating the Company's financial performance. Free Cash Flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of our performance and net cash provided by operating activities as a measure of our liquidity.
"Adjusted EBITDA" is defined as EBITDA (earnings before depreciation and amortization, depreciation and interest in cost of sales, income taxes, and interest) less accretion, loss from discontinued operations, one-time transaction costs and all other non-cash items. The Company has presented "Adjusted EBITDA" because its management believes it is a useful measure for investors when assessing and considering the Company's continuing operations and prospects for the future. Furthermore, "Adjusted EBITDA" is a commonly used measurement in the financial community when evaluating the market value of similar companies.
About C21 Investments Inc.C21 Investments Inc. is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry-leading retail revenues with high-growth potential multi-market branded consumer packaged goods. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Based in Vancouver, Canada, additional information on C21 can be found at www.sedarplus.com and www.cxxi.ca.
Cautionary Note Regarding Forward-Looking Information and Statements:
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, "Forward-Looking Statements"). Forward-Looking Statements in this news release include but are not limited to the Company's focus on ramping its new store and continuing to pursue additional opportunities in the market; and improving margins. Such Forward-Looking Statements represent the Company's beliefs and expectations regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.
Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: achieving the anticipated results of the Company's strategic plans; and general economic, financial market, regulatory and political conditions in which the Company operates.
A variety of factors, including known and unknown risks, many of which are beyond the Company's control, could cause actual results to differ materially from the Forward-Looking Statements in this news release. Such factors include, without limitation: risks and uncertainties arising from: the inability to effectively manage growth; inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; the adequacy of the Company's capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute the Company's business plan (either within the expected timeframe or at all); changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana; the risks of operating in the marijuana industry in the United States, and those other risk factors discussed in the Company's 20F filing with the U.S. Securities and Exchange Commission and Annual Information Form filing on SEDAR+.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the Forward-Looking Statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such Forward-Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Should assumptions underlying the Forward-Looking Statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
The Forward-Looking Statements contained in this news release are made as of the date of this news release, and the Company does not undertake to update any Forward-Looking Statements that are contained or referenced herein, except in accordance with applicable securities laws.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
1 Refer to "Non-GAAP Measures" disclosure at the end of this news release for a description and calculation of these measures
SOURCE C21 Investments Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/22/c2026.html
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced a reverse stock split of its issued and outstanding shares of common stock, par value $0.005 per share (the 'Common Stock'), at a ratio of 1-for-15, effective June 12, 2025 at 12:01 a.m. Eastern Time. The Company's Common Stock is expected to begin trading on a split-adjusted basis when the market opens on June 12, 2025, under the existing trading symbol 'ERNA.' The Company is effecting the reverse split to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The new CUSIP number following the reverse stock split will be 114082 308. As a result of the reverse stock split, every 15 shares of the Company's Common Stock issued and outstanding will be automatically reclassified into one new share of Common Stock. The reverse stock split will not modify any rights or preferences of the shares of the Company's Common Stock. Proportionate adjustments will be made to the exercise prices and the number of shares underlying the Company's outstanding equity awards, as applicable, and warrants, as well as to the number of shares issued and issuable under the Company's equity incentive plans. The Common Stock issued pursuant to the reverse stock split will remain fully paid and non-assessable. The reverse stock split will not affect the number of authorized shares of Common Stock or the par value of the Common Stock. The reverse stock split was approved by the Company's stockholders at the Company's Annual Meeting of Stockholders held on June 2, 2025 at a ratio in the range of 1-for-10 to 1-for-15, such ratio to be determined by the Board of Directors. The Company's Board of Directors approved the reverse stock split at the ratio of 1-for-15. No fractional shares will be issued in connection with the reverse stock split, and no cash or other consideration will be paid in connection with any fractional shares. Stockholders who otherwise would have held a fractional share after giving effect to the reverse stock split will instead own one whole share of the post-reverse stock split Common Stock. As of the date of this press release, the Company had 110,418,022 shares of Common Stock issued and outstanding, which it anticipates will result in approximately 7,361,201 shares of Common Stock issued and outstanding on a split-adjusted basis, without giving effect to any rounding for fractional shares. Computershare Inc. and its affiliate Computershare Trust Company, N.A., the Company's transfer agent (collectively, 'Computershare'), will act as the exchange agent for the reverse stock split. Stockholders of record holding certificates representing pre-split shares of the Company's Common Stock will receive a letter of transmittal from Computershare with instructions on how to surrender certificates representing pre-split shares. Stockholders should not send in their pre-split certificates until they receive a letter of transmittal from Computershare. Stockholders with book-entry shares or who hold their shares through a bank, broker, or other nominee will not need to take any action. Stockholders of record who held pre-split certificates will receive their post-split shares in book-entry form and will receive a statement from Computershare regarding their Common Stock ownership post-reverse stock split. Additional information about the reverse stock split can be found in the Company's definitive proxy statement filed with the Securities and Exchange Commission (the 'SEC') on April 14, 2025, which is available at and on the Company's website at Alongside Ernexa's recent financings and corporate restructuring, the Company believes this reverse stock split is a key step in strengthening its financial foundation and maintaining access to the capital markets needed to advance its clinical programs. About Ernexa Therapeutics Ernexa Therapeutics (NASDAQ: ERNA) is developing innovative stem cell therapies for the treatment of advanced cancer and autoimmune disease. Ernexa's core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). Ernexa's allogeneic synthetic iMSCs provide a scalable, off-the-shelf treatment, without needing patient-specific cell harvesting. ERNA-101 is the company's lead cell therapy product, designed to activate and regulate the immune system's response to recognize and attack cancer cells. ERNA-102 is a cell therapy product designed to target inflammation and treat autoimmune disease. The company's initial focus is to develop ERNA-101 for the treatment of ovarian cancer. For more information, visit Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, in some cases, can be identified by terms such as "believe," "may," "will," "estimate," "continue," "anticipate," "design," "intend," "expect," "could," "plan," "potential," "predict," "seek," "should," "would," "contemplate," "project," "target," "objective," or the negative version of these words and similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Ernexa's actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, without limitation, risks and uncertainties related to the impact of the reverse stock split. Forward-looking statements are based upon Ernexa's current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. For a detailed description of Ernexa's risks and uncertainties, you are encouraged to review its documents filed with the SEC including its recent filings on Form 8-K, Form 10-K and Form 10-Q. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Ernexa does not undertake any obligation to update the forward-looking statements contained herein to reflect events that occur or circumstances that exist after the date hereof, except as required by applicable law. Media & Investor Relations Contact investors@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
GrowGeneration Announces International Expansion with Distribution Agreement Across the European Union and Footprint in Costa Rica
DENVER, June 10, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) ('GrowGen' or the 'Company'), the nation's largest specialty retailer of hydroponic and organic gardening products, today announced it has entered into a distribution agreement with V1 Solutions, a Macedonia-based company that will act as GrowGen's sales and marketing partner for its proprietary product lines throughout the European Union. Additionally, the Company announced the distribution of its proprietary products in Costa Rica, making its products available to cultivators in Central America. Targeted EU Expansion Driven by Evolving Cannabis LandscapeV1 Solutions has developed and maintains key strategic relationships with commercial cultivators across the European region. This agreement enables GrowGen to meet the growing demand for advanced cultivation products that comply with evolving regulatory and quality standards as cannabis reform accelerates across the European Union. Target markets include: Germany, where recreational cannabis was legalized in 2024, unlocking significant commercial and medical cultivation potential. Portugal, a leading exporter of medical cannabis to the EU and a hub for EU-GMP-certified cultivation. Malta and Luxembourg, which have enacted progressive cannabis reform and are scaling their domestic cultivation industries. The Netherlands, launching pilot adult-use programs with government-licensed growers. Czech Republic and Greece, where updated regulatory frameworks are attracting major cultivation investments. Macedonia, as a strategic Balkan hub supporting EU-facing cannabis production. Uruguay, a pioneer in cannabis legalization, opening doors for broader South American market expansion. GrowGeneration will supply commercial cultivators, garden centers, and licensed operators in these countries with its proprietary brands—Drip Hydro, Char Coir, Ion Lighting, Power Si, and The Harvest Company—designed by growers for growers. Costa Rica: Gateway to Central American ExpansionGrowGen has also launched its proprietary brands in Costa Rica, whose government has issued over 50 licenses for hemp and cannabis production during the past year. The country's favorable growing conditions and developing export infrastructure make it a key growth market in Central America. 'As legalization advances, the EU and Costa Rica are rapidly becoming some of the most promising cannabis cultivation markets in the world,' said Darren Lampert, GrowGen's Co-Founder and Chief Executive Officer. 'We are thrilled to bring our proven product lines to professional growers across Europe and Central America, who are seeking yield-maximizing, cost-effective solutions backed by North American cultivation expertise.' International Expansion StrategyGrowGen is actively exploring additional markets in Eastern Europe and Latin America, consistent with its strategy to serve high-growth regions through local partnerships and product education. GrowGeneration's international expansion activities align with its. The Company's international sales infrastructure, regulatory expertise, and strong distribution network position it to capitalize on the cannabis cultivation boom in regions where legalization continues to advance. About GrowGeneration Corp:GrowGen is the nation's largest specialty hydroponic and organic gardening retailer. GrowGen carries and sells thousands of products, such as nutrients, additives, growing media, lighting, environmental control systems, and benching and racking, including proprietary brands such as Charcoir, Drip Hydro, Power Si, Ion lights, The Harvest Company, and more. The Company also operates an online superstore for cultivators at as well as a wholesale business for resellers, and a benching, racking, and storage solutions business, Mobile Media or MMI. To be added to the GrowGeneration email distribution list, please email GrowGen@ with GRWG in the subject line. Forward Looking Statements:This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect opinions only as of the date of this release. Please keep in mind that the Company does not have an obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as 'look forward,' 'expect,' 'believe,' 'anticipate,' 'estimate,' or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings made with the United States Securities and Exchange Commission, available at: and on the Company's website, at: Contacts:KCSA Strategic CommunicationsPhilip CarlsonManaging DirectorT: 212-896-1233E: GrowGen@
Newsweek
2 hours ago
- Newsweek
Retail Layoffs Soar Nearly 300% So Far This Year
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Retail layoffs have soared in 2025, driven by new economic difficulties for the sector, its long term battles with reduced foot traffic, and the growing dominance of e-commerce, according to analysis by outplacement firm Challenger, Gray & Christmas (CGC). In May, retailers announced 11,483 job cuts, up from 7,235 in the previous month. This brings the total this year to 75,802 for the sector, up 274 percent from the 20,276 cuts announced in the first five months of 2024. Why It Matters CGC attributed layoffs across all sectors last month to the impact of President Donald Trump's tariffs, as well as persistent "economic pessimism" and the broader decline in consumer confidence. These recent developments have compounded with the longer-term decline in foot traffic and rise of online shopping that have for years plagued the retail sector — the nation's largest private sector employer, according to the National Retail Federation, which supports over one-in-four American jobs. What To Know Overall, total U.S. announced job cuts dropped 12 percent in May to 93,816, from 105,441 in April. However, this figure was still up 47 percent from the same month last year. In 2025, employers have announced 696,309 job cuts, up 80 percent from the 385,859 announced in the first five months of last year. As CGC noted, it would take only 65,049 cuts to surpass the total announced in 2024. The services sector led the way last month, with 22,492 cuts amounting for the highest monthly figure since May 2020, at the height of the COVID-19 pandemic. Only government job cuts have surpassed those seen in the retail sector this year, owing primarily to the aggressive cost-cutting efforts pursued by the Department of Government Efficiency (DOGE). Shown is Walmart retail location in Philadelphia, Wednesday, June 4, 2025. Shown is Walmart retail location in Philadelphia, Wednesday, June 4, 2025. Matt Rourke/AP Photo Several prominent retailers have announced layoffs in recent weeks, including Nike, pharmacy chain CVS and Walmart, which confirmed to Newsweek that nearly 1,500 employees would be let go in a restructuring push aimed at improving company-wide efficiencies. CGC's report came ahead of the official Non-Farm Payrolls data from the Bureau of Labor Statistics, which showed a decline in new jobs to 139,000 from 147,000 in April. The results were weighed down by the loss of 22,000 federal workers, though the unemployment rate remained flat at 4.2 percent. In the private sector, hiring has failed to keep up with the pace of job cuts, according to two recent reports from payroll firm ADP and the National Federation of Independent Business (NFIB), which showed the pace of hiring slowing in May and small businesses reporting persistently low levels of job openings. What People Are Saying Andrew Challenger, Senior Vice President of Challenger, Gray & Christmas said: "Tariffs, funding cuts, consumer spending, and overall economic pessimism are putting intense pressure on companies' workforces. Companies are spending less, slowing hiring, and sending layoff notices." Nicole Leinbach Hoffman, founder and president of and STIMULATE: A B2B Sexual Wellness Trade Show, told Newsweek: "Supply chain disruptions, increased competition, and changing consumer habits - including online buying - are all strong influencers to the challenges facing retailers and more so, why many merchants are increasing their layoffs. Keeping this in mind, the real reason, however, is that these same merchants may not have pivoted as effectively as needed during these challenges to withstand the current stresses in retail and thus, layoffs are the result. Being proactive to be profitable should always be the goal of a retailers, and timing is a big part of this reality." What Happens Next? According to CGC, American employers have announced 79,741 planned hires in the year so far, up 57 percent from 2024. However, the firm noted that this figure remains "historically low when compared to pre-pandemic and early-pandemic years."
